- Home
- RELL vs UNCY Comparison
RELL vs UNCY Comparison
Compare RELL & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELL | UNCY |
|---|---|---|
| Founded | 1947 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.3M | 145.3M |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RELL | UNCY |
|---|---|---|
| Price | $17.79 | $7.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | 319.4K | ★ 680.8K |
| Earning Date | 04-08-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $208,909,000.00 | $675,000.00 |
| Revenue This Year | $6.32 | N/A |
| Revenue Next Year | $7.91 | $582.86 |
| P/E Ratio | $230.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.79 | $0.47 |
| 52 Week High | $19.86 | $8.74 |
Technical Indicators
Market Signals| Indicator | RELL | UNCY |
|---|---|---|
| Relative Strength Index (RSI) | 61.83 | 45.43 |
| Support Level | $10.10 | $7.05 |
| Resistance Level | $19.86 | $7.34 |
| Average True Range (ATR) | 1.56 | 0.56 |
| MACD | -0.05 | -0.11 |
| Stochastic Oscillator | 56.79 | 20.00 |
Price Performance
Historical ComparisonAbout RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.